These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 33785312)
1. CT and MRI characteristics of ovarian mature teratoma in patients with anti-N-methyl-D-aspartate receptor encephalitis. Kawaguchi M; Kato H; Noda Y; Suzui N; Miyazaki T; Furui T; Morishige KI; Matsuo M Diagn Interv Imaging; 2021; 102(7-8):447-453. PubMed ID: 33785312 [TBL] [Abstract][Full Text] [Related]
2. Anti-N-methyl-D-aspartate receptor encephalitis with accompanying ovarian teratoma in female patients from East China: Clinical features, treatment, and prognostic outcomes. Zhang L; Lu Y; Xu L; Liu L; Wu X; Zhang Y; Zhu G; Hong Z Seizure; 2020 Feb; 75():55-62. PubMed ID: 31874360 [TBL] [Abstract][Full Text] [Related]
3. 'Benign' ovarian teratoma and N-methyl-D-aspartate receptor (NMDAR) encephalitis in a child. Frawley KJ; Calvo-Garcia MA; Krueger DA; McMasters RL Pediatr Radiol; 2012 Jan; 42(1):120-3. PubMed ID: 21611826 [TBL] [Abstract][Full Text] [Related]
4. Ovarian Teratomas in Women With Anti-N-methyl-D-Aspartate Receptor Encephalitis: Topography and Composition of Immune Cell and Neuroglial Populations Is Compatible With an Autoimmune Mechanism of Disease. Nolan A; Buza N; Margeta M; Rabban JT Am J Surg Pathol; 2019 Jul; 43(7):949-964. PubMed ID: 31021857 [TBL] [Abstract][Full Text] [Related]
6. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma. Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109 [TBL] [Abstract][Full Text] [Related]
7. Anti-NMDAR encephalitis with ovarian teratomas: Review of the literature and two case reports. Chiu HC; Su YC; Huang SC; Chiang HL; Huang PS Taiwan J Obstet Gynecol; 2019 May; 58(3):313-317. PubMed ID: 31122515 [TBL] [Abstract][Full Text] [Related]
8. Anti-N-methyl-D-aspartate receptor encephalitis induced by bilateral ovarian teratomas with distinct histopathologic types: A case report and brief literature review. Li W; Jia D; Tong L; Lun Z; Li H Medicine (Baltimore); 2019 Nov; 98(48):e18148. PubMed ID: 31770255 [TBL] [Abstract][Full Text] [Related]
9. Anti-N-Methyl-D-Aspartate Receptor Encephalitis Associated with Ovarian Teratoma in South China-Clinical Features, Treatment, Immunopathology, and Surgical Outcomes of 21 Cases. Jiang H; Ye H; Wang Y; Li Y; Wang Y; Li X Dis Markers; 2021; 2021():9990382. PubMed ID: 34093900 [TBL] [Abstract][Full Text] [Related]
10. Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. Dabner M; McCluggage WG; Bundell C; Carr A; Leung Y; Sharma R; Stewart CJ Int J Gynecol Pathol; 2012 Sep; 31(5):429-37. PubMed ID: 22833082 [TBL] [Abstract][Full Text] [Related]
11. The N-methyl-D-aspartate receptor, a precursor to N-methyl-D-aspartate receptor encephalitis, is found in the squamous tissue of ovarian teratomas. Clark RM; Lynch MP; Kolp R; Zukerberg LR; Growdon WB; Rueda BR Int J Gynecol Pathol; 2014 Nov; 33(6):598-606. PubMed ID: 25272299 [TBL] [Abstract][Full Text] [Related]
12. Immunopathological significance of ovarian teratoma in patients with anti-N-methyl-d-aspartate receptor encephalitis. Tabata E; Masuda M; Eriguchi M; Yokoyama M; Takahashi Y; Tanaka K; Yukitake M; Horikawa E; Hara H Eur Neurol; 2014; 71(1-2):42-8. PubMed ID: 24296881 [TBL] [Abstract][Full Text] [Related]
14. Abnormal neurons in teratomas in NMDAR encephalitis. Day GS; Laiq S; Tang-Wai DF; Munoz DG JAMA Neurol; 2014 Jun; 71(6):717-24. PubMed ID: 24781184 [TBL] [Abstract][Full Text] [Related]
15. N-Methyl-D-Aspartate Receptor Encephalitis with Psychiatric Symptoms and an Ovarian Teratoma Detected by MRI in a 17-Year-Old Girl. Barth A; Nassenstein I; Tröbs RB; Tannapfel A; Dercks H; Rostásy K; Wegener-Panzer A Neuropediatrics; 2019 Aug; 50(4):253-256. PubMed ID: 31163454 [TBL] [Abstract][Full Text] [Related]
16. Does MAP2 have a role in predicting the development of anti-NMDAR encephalitis associated with benign ovarian teratoma? A report of six new pediatric cases. Cundiff CA; Elawabdeh N; Naguib MM; Jactel SN; Demellawy DE; Abramowsky CR; Durham MM; Youssef L; Wittkamp ML; Shehata BM Pediatr Dev Pathol; 2015; 18(2):122-6. PubMed ID: 25569473 [TBL] [Abstract][Full Text] [Related]
17. [Localization of NMDAR-related epitopes in ovarian teratoma: comparison between patients and controls]. Tachibana N; Ikeda S Rinsho Shinkeigaku; 2012; 52(11):982-4. PubMed ID: 23196491 [TBL] [Abstract][Full Text] [Related]
18. Anti-NMDAR encephalitis with delayed ovarian teratoma in a young woman: a case report with 5 years of follow-up. Xue H; Hu J; Chen Y; Huang W; Liu H; Xu H; Shi M BMC Neurol; 2024 Oct; 24(1):377. PubMed ID: 39375580 [TBL] [Abstract][Full Text] [Related]
19. Research progress in teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis: The gynecological perspective. Gu J; Chen Q; Gu H; Duan R J Obstet Gynaecol Res; 2021 Nov; 47(11):3749-3757. PubMed ID: 34396640 [TBL] [Abstract][Full Text] [Related]
20. Rate of Anti-NMDA Receptor Encephalitis in Ovarian Teratomas. Li JH; Milla SS; Gombolay GY Neuropediatrics; 2022 Apr; 53(2):133-135. PubMed ID: 34872133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]